U.S., Feb. 5 -- ClinicalTrials.gov registry received information related to the study (NCT06807502) titled 'Evaluation of Circulating Tumor Cells (CTC) Relevance in Breast Cancer Follow-up Using the ScreenCell Device' on Jan. 14.
Brief Summary: Liquid biopsy is a noninvasive method for detecting and quantifying circulating tumor cells (CTCs). Thanks to ScreenCell technology, this study aims to evaluate the evolution of the number of CTCs during breast cancer follow-up.
The identification and characterization of CTCs would make it possible to obtain information on the stage and molecular characteristics of cancer during follow-up
Study Start Date: Feb. 01
Study Type: INTERVENTIONAL
Condition:
Breast Cancer, Metastatic
Breast Cancer Inv...